Pfizer seeks FDA authorization of COVID-19 vaccine for children ages 5 to 11
Pfizer began submitting its data on the vaccine for younger children to the FDA late last month, but had not formally requested authorization until now. |!| Chattanooga
Pfizer began submitting its data on the vaccine for younger children to the FDA late last month, but had not formally requested authorization until now. |!| Chattanooga